Treatment


Our Pulmonary Hypertension Program has experience transitioning patients from parenteral to nebulized prostacyclin therapy over a period of 48 to 72 hours.

Pharmacotherapy Information

Pharmacotherapy Class
Medication Name
Endothelin receptor antagonists
  • Bosentan (Tracleer), ambrisentan (Letairis), macitentan (Opsumit)
Phosphodiesterase-5 inhibitors
  • Sildenafil (Revatio), tadalafil (Adcirca)
Soluble guanylate cyclase stimulator
  • Riociguat (Adempas)
Prostacyclins
  • Oral: treprostinil (Orenitram)
  • Nebulized: treprostinil (Tyvaso), iloprost (Ventavis), epoprostenol (Flolan)
  • Intravenous: epoprostenol (Flolan, Veletri), treprostinil (Remodulin)
  • Subcutaneous: treprostinil (Remodulin)